JAGSONPAL PHARMACEUTICALS
|
The Current P/E Ratio of JAGSONPAL PHARMACEUTICALS is 35.32.
| Share Price | ₹231.3 | Jun 29,2026 |
| Market Cap | ₹1,521.6 Cr | |
| Earnings-TTM | ₹43.1 Cr | TTM-Standalone Results |
| Price/Earnings | 35.32x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of JAGSONPAL PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,521.6 Cr] as on Jun 29,2026
(/) Earnings [ ₹43.1 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 35.32x ]
Thus, for JAGSONPAL PHARMACEUTICALS , the investors are currently willing to pay 35.32 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of JAGSONPAL PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of JAGSONPAL PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of JAGSONPAL PHARMACEUTICALS
PE Ratio Performance Analysis for JAGSONPAL PHARMACEUTICALS
- JAGSONPAL PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 24.66x.
- JAGSONPAL PHARMACEUTICALS 's operated at median p/e ratio of 25.9x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, JAGSONPAL PHARMACEUTICALS 's p/e ratio peaked in Mar2022 at 43.57x.
- JAGSONPAL PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 12.22x.
How does JAGSONPAL PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| JAGSONPAL PHARMACEUTICALS | 43.08 | 35.32 | 1,521.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 38.85 | 449,299.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 67.84 | 174,207.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 73.77 | 157,721.0 |
| CIPLA LTD | 3,869.79 | 30.34 | 117,420.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 27.72 | 114,876.0 |
| MANKIND PHARMA LTD | 1,926.41 | 53.28 | 102,642.0 |
| LUPIN LTD | 5,355.47 | 20.55 | 110,076.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 22.26 | 111,885.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.45 | 89,117.4 |
| LAURUS LABS LTD | 889.85 | 91.24 | 81,194.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs JAGSONPAL PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 20.55x |
| Max industry PE | 91.24x |
| Median industry PE | 35.32x |
| Average industry PE | 44.24x |
You may also like the below Video Courses